Pathology
|
Fluoroquinolone
|
Fortified-Combined
|
Total numbers
|
Corneal conditions: | | | |
Scar | | | |
HSV stromal keratitis | 35 (64.8%) | 45 (53.5%) | 70 (48.6%) |
Trophic cornea | 13 (24.0%) | 13 (14.0%) | 26 (18.2%) |
Oedema | 7 (13.0%) | 9 (9.6%) | 16 (11.6%) |
Other conditions: | | | |
Pterygium | 4 (7.4%) | 4 (4.8%) | 8 (5.6%) |
Spheroidal degeneration | 7 (13.0%) | 11 (11.7%) | 18 (13.0%) |
Inflammation | 4 (7.4%) | 8 (9.5%) | 12(8.7%) |
Associated lid conditions: | 12 (22.3%) | 13 (15.5%) | 25 (18.1%) |
Lagophthalmos | 9 (16.7%) | 8 (9.5%) | 17 (12.3%) |
Other conditions: | | | |
Trauma | 7 (13.0%) | 18 (13.0%) | 25 (18.1%) |
Past surgery | 26 (48.0%) | 27 (32.0%) | 53 (38.4%) |
Dry eye | 7 (13.0%) | 1 (1.4%) | 8 (5.8) |
Glaucoma | 12 (22.2%) | 18 (21.4%) | 30 (21.7%) |
Viral keratitis +Rx | 5 (9.2%) | 7 (8.3%) | 12 (8.7%) |
Antiglaucoma Rx | 12 (22.2%) | 24 (26.0%) | 36 (26.0%) |
Contact lens | 5 (9.2%) | 14 (16.6%) | 19 (14.4%) |